Nature Reviews Molecular Cell Biology, volume 23, issue 1, pages 3-20

Mechanisms of SARS-CoV-2 entry into cells

Cody B Jackson 1, 2
Michael Farzan 1
Bing Chen 3, 4
Hyeryun Choe 1
Publication typeJournal Article
Publication date2021-10-05
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor112.7
ISSN14710072, 14710080
Molecular Biology
Cell Biology
Abstract
The unprecedented public health and economic impact of the COVID-19 pandemic caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been met with an equally unprecedented scientific response. Much of this response has focused, appropriately, on the mechanisms of SARS-CoV-2 entry into host cells, and in particular the binding of the spike (S) protein to its receptor, angiotensin-converting enzyme 2 (ACE2), and subsequent membrane fusion. This Review provides the structural and cellular foundations for understanding the multistep SARS-CoV-2 entry process, including S protein synthesis, S protein structure, conformational transitions necessary for association of the S protein with ACE2, engagement of the receptor-binding domain of the S protein with ACE2, proteolytic activation of the S protein, endocytosis and membrane fusion. We define the roles of furin-like proteases, transmembrane protease, serine 2 (TMPRSS2) and cathepsin L in these processes, and delineate the features of ACE2 orthologues in reservoir animal species and S protein adaptations that facilitate efficient human transmission. We also examine the utility of vaccines, antibodies and other potential therapeutics targeting SARS-CoV-2 entry mechanisms. Finally, we present key outstanding questions associated with this critical process. Entry of SARS-CoV-2 into host cells is mediated by the interaction between the viral spike protein and its receptor angiotensin-converting enzyme 2, followed by virus–cell membrane fusion. Worldwide research efforts have provided a detailed understanding of this process at the structural and cellular levels, enabling successful vaccine development for a rapid response to the COVID-19 pandemic.

Top-30

Citations by journals

10
20
30
40
50
60
70
80
90
International Journal of Molecular Sciences
84 publications, 4.88%
Viruses
78 publications, 4.53%
Frontiers in Immunology
48 publications, 2.79%
Vaccines
23 publications, 1.33%
Scientific Reports
22 publications, 1.28%
Nature Communications
21 publications, 1.22%
Journal of Virology
19 publications, 1.1%
Cells
18 publications, 1.04%
Journal of Medical Virology
18 publications, 1.04%
Biomedicines
14 publications, 0.81%
Frontiers in Cellular and Infection Microbiology
14 publications, 0.81%
Frontiers in Microbiology
14 publications, 0.81%
Antiviral Research
13 publications, 0.75%
Heliyon
13 publications, 0.75%
mBio
12 publications, 0.7%
Proceedings of the National Academy of Sciences of the United States of America
12 publications, 0.7%
Microorganisms
11 publications, 0.64%
iScience
11 publications, 0.64%
Microbiology spectrum
11 publications, 0.64%
PLoS Pathogens
10 publications, 0.58%
Journal of Biomolecular Structure and Dynamics
10 publications, 0.58%
Frontiers in Pharmacology
10 publications, 0.58%
Signal Transduction and Targeted Therapy
10 publications, 0.58%
Life
9 publications, 0.52%
Journal of Clinical Medicine
9 publications, 0.52%
Frontiers in Molecular Biosciences
9 publications, 0.52%
Molecules
9 publications, 0.52%
ACS Omega
9 publications, 0.52%
Pathogens
8 publications, 0.46%
10
20
30
40
50
60
70
80
90

Citations by publishers

50
100
150
200
250
300
350
Multidisciplinary Digital Publishing Institute (MDPI)
339 publications, 19.67%
Elsevier
299 publications, 17.35%
Springer Nature
237 publications, 13.76%
Frontiers Media S.A.
133 publications, 7.72%
Cold Spring Harbor Laboratory
128 publications, 7.43%
Wiley
92 publications, 5.34%
American Chemical Society (ACS)
69 publications, 4%
American Society for Microbiology
47 publications, 2.73%
Taylor & Francis
34 publications, 1.97%
Public Library of Science (PLoS)
21 publications, 1.22%
Royal Society of Chemistry (RSC)
19 publications, 1.1%
Oxford University Press
19 publications, 1.1%
American Association for the Advancement of Science (AAAS)
13 publications, 0.75%
Proceedings of the National Academy of Sciences (PNAS)
12 publications, 0.7%
Bentham Science
11 publications, 0.64%
Wolters Kluwer Health
10 publications, 0.58%
Baishideng Publishing Group
9 publications, 0.52%
Mary Ann Liebert
8 publications, 0.46%
SAGE
8 publications, 0.46%
Pleiades Publishing
8 publications, 0.46%
Research Square Platform LLC
8 publications, 0.46%
eLife Sciences Publications
8 publications, 0.46%
S. Karger AG
6 publications, 0.35%
Dove Medical Press
5 publications, 0.29%
The Endocrine Society
4 publications, 0.23%
F1000 Research
4 publications, 0.23%
Thieme
4 publications, 0.23%
American Physiological Society
4 publications, 0.23%
Annual Reviews
4 publications, 0.23%
50
100
150
200
250
300
350
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Jackson C. B. et al. Mechanisms of SARS-CoV-2 entry into cells // Nature Reviews Molecular Cell Biology. 2021. Vol. 23. No. 1. pp. 3-20.
GOST all authors (up to 50) Copy
Jackson C. B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells // Nature Reviews Molecular Cell Biology. 2021. Vol. 23. No. 1. pp. 3-20.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41580-021-00418-x
UR - https://doi.org/10.1038/s41580-021-00418-x
TI - Mechanisms of SARS-CoV-2 entry into cells
T2 - Nature Reviews Molecular Cell Biology
AU - Jackson, Cody B
AU - Farzan, Michael
AU - Chen, Bing
AU - Choe, Hyeryun
PY - 2021
DA - 2021/10/05 00:00:00
PB - Springer Nature
SP - 3-20
IS - 1
VL - 23
PMID - 34611326
SN - 1471-0072
SN - 1471-0080
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Jackson,
author = {Cody B Jackson and Michael Farzan and Bing Chen and Hyeryun Choe},
title = {Mechanisms of SARS-CoV-2 entry into cells},
journal = {Nature Reviews Molecular Cell Biology},
year = {2021},
volume = {23},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1038/s41580-021-00418-x},
number = {1},
pages = {3--20},
doi = {10.1038/s41580-021-00418-x}
}
MLA
Cite this
MLA Copy
Jackson, Cody B., et al. “Mechanisms of SARS-CoV-2 entry into cells.” Nature Reviews Molecular Cell Biology, vol. 23, no. 1, Oct. 2021, pp. 3-20. https://doi.org/10.1038/s41580-021-00418-x.
Found error?